Norris Medicines Limited (BOM:524414)

India flag India · Delayed Price · Currency is INR
15.00
+0.71 (4.97%)
At close: Mar 10, 2026
-12.23%
Market Cap 150.01M
Revenue (ttm) 94.44M
Net Income (ttm) -5.60M
Shares Out 10.00M
EPS (ttm) -0.56
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 788
Average Volume 1,289
Open 14.25
Previous Close 14.29
Day's Range 13.56 - 15.00
52-Week Range 12.50 - 22.10
Beta -0.88
RSI 55.44
Earnings Date Feb 10, 2026

About Norris Medicines

Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exp... [Read more]

Industry Pharmaceutical Preparations
Founded 1990
Employees 33
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524414
Full Company Profile

Financial Performance

In fiscal year 2025, Norris Medicines's revenue was 58.20 million, an increase of 3.27% compared to the previous year's 56.36 million. Losses were -12.37 million, 4.28% more than in 2024.

Financial Statements

News

There is no news available yet.